Platform
Features
0 followers
GigaMune was founded as a spin-out from GigaGen in 2017. They are combining unique insight into T cell responses to tumors with massively parallel T cell receptor (TCR) discovery to develop the next generation of T cell therapies.
Industries
Stage
Employees
Links
David Johnson
Merck
190 followers
Alkeus Pharmaceuticals
1 follower
ALS Therapy Development Institute
3 followers
GenPAx
Charm Therapeutics
Discover companies
